Recent activity shows that Hims & Hers Health, HIMS the Insider Confidence level is trending Up due to Corporate Insiders of HIMS Bought $456.6K worth of shares in the last 3 months. With that said, our editors here at techstockmovers.com, are adding HIMS to our watchlist to see if this momentum continues.
Before you dig into this report it is important to remember that "Insider Buying" is the purchase of shares in a corporation by a director, officer, or executive within the company. Insider buying is not the same as insider trading, which refers to corporate insiders making illegal stock purchases based on non-public information.
"Insider Buying" is not a crime when the buying is based on public information.
Additionally, since insiders have unique insights into their own companies, they often gobble up shares when they believe the stock is undervalued or dump stock when it’s time to sell. That's why people pay attention to insider buying.
Here is a list of the latest insider activity for HIMS stock:
In addition, TradingView issued a Buy rating for HIMS over the next month, Barchart.com has a Weak sell rating and Yahoo! Finance has a Bullish short-term outlook.
Hims & Hers Health, HIMS
Summary: Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
TechStockMovers.com keeps investors informed on a variety of tech stocks including communications equipment, IT Services, Semiconductors, Software, Technical hardware, storage and peripherals, artificial intelligence (AI), cybersecurity and more. (TSM) aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Disclaimer: Sandpiper Marketing Group, LLC would like to remind you the data contained in this website is not necessarily real-time nor accurate. All stocks, indexes, futures and Forex prices are not provided by exchanges but rather by our editor research at the time of writing this release, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Sandpiper Marketing does not bear any responsibility for any trading losses you might incur as a result of using this data. Sandpiper Marketing Group, LLC or anyone involved with Sandpiper Marketing Group, LLC will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in this website/newsletter is not trustworthy unless verified by their own research. Also, because events/circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
==============================================================================
Before you dig into this report it is important to remember that "Insider Buying" is the purchase of shares in a corporation by a director, officer, or executive within the company. Insider buying is not the same as insider trading, which refers to corporate insiders making illegal stock purchases based on non-public information.
"Insider Buying" is not a crime when the buying is based on public information.
Additionally, since insiders have unique insights into their own companies, they often gobble up shares when they believe the stock is undervalued or dump stock when it’s time to sell. That's why people pay attention to insider buying.
Here is a list of the latest insider activity for HIMS stock:
- O'Keefe Lynne Chou - Director, Sold $43,696 worth of shares of HIMS stock on 6 days ago
- Jules Maltz - Director,>10% Owner, Bought $274,487 worth of shares of HIMS stock on 1 week ago
- Jules Maltz - Director,>10% Owner, Bought $199,500 worth of shares of HIMS stock on 2 weeks ago
- Okupe Oluyemi - CFO, Bought $26,325 worth of worth of shares of HIMS stock on shares on 1 month ago
In addition, TradingView issued a Buy rating for HIMS over the next month, Barchart.com has a Weak sell rating and Yahoo! Finance has a Bullish short-term outlook.
Hims & Hers Health, HIMS
Summary: Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
- Last Price: $4.76
- Price Change: $0.18, 3.93%
- Yearly Gain: -56.29%
- Market Cap: $980.86M
- P/E Ratio: -13.138
TechStockMovers.com keeps investors informed on a variety of tech stocks including communications equipment, IT Services, Semiconductors, Software, Technical hardware, storage and peripherals, artificial intelligence (AI), cybersecurity and more. (TSM) aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Disclaimer: Sandpiper Marketing Group, LLC would like to remind you the data contained in this website is not necessarily real-time nor accurate. All stocks, indexes, futures and Forex prices are not provided by exchanges but rather by our editor research at the time of writing this release, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Sandpiper Marketing does not bear any responsibility for any trading losses you might incur as a result of using this data. Sandpiper Marketing Group, LLC or anyone involved with Sandpiper Marketing Group, LLC will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in this website/newsletter is not trustworthy unless verified by their own research. Also, because events/circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
==============================================================================